参考文献: 1. 张秀丽,仝莹莹,张莲,等.肿瘤免疫治疗新进展及面临挑战[J].癌症进展,2016,14(2):129. 2. 钱其军.肿瘤免疫治疗何去何从:多角度的换位思考[J].中国肿瘤生物治疗杂志,2016,23(3):308. 3. Umemoto Y, Okano S, Matsumoto Y, et al. Prognostic impact of programmed cell death 1 ligand 1 expression in human leukocyte antigen class I-positive hepatocellular carcinoma after curative hepatectomy[J]. Gastroenterol, 2015, 50(1):65-75. 4. JeremyC,XIE W,CharlesZ,et al.Immunotherapy and cell therapy for cancer[J]. Chin J Pharmacol Toxicol,2016,30(2),87. 5. 部分数据、资料来源于药渡网.
作者信息 作者:强森 职业从事新药开发
|